Intra-Cellular Therapies research and development expenses for the twelve months ending December 31, 2024 were $0.236B, a 31.07% increase year-over-year.
Intra-Cellular Therapies annual research and development expenses for 2024 were $0.236B, a 31.07% increase from 2023.
Intra-Cellular Therapies annual research and development expenses for 2023 were $0.18B, a 33.72% increase from 2022.
Intra-Cellular Therapies annual research and development expenses for 2022 were $0.135B, a 51.63% increase from 2021.
Intra-Cellular Therapies Research and Development Expenses 2013-2024 | ITCI